Abstract
Purpose
Treating segmental long-bone defects remains a major challenge. For defects >3 cm, segmental transport represents the gold standard, even though the method is time consuming and afflicted with several complications. The aim of this study was to evaluate healing of such defects after grafting an osteogenic scaffold previously seeded with stem cell concentrate.
Methods
We evaluated five patients with segmental long-bone defects (3–14 cm) treated with bone marrow aspirate concentrates (BMAC) seeded onto a bovine xenogenous scaffold. The healing process was monitored by X-rays and positron emission tomography–computed tomography (PET-CT) three months after surgery.
Results
Centrifugation led to a concentration of leukocytes by factor 8.1 ± 7.5. Full weight bearing was achieved 11.3 ± 5.0 weeks after surgery. PET analysis showed an increased influx of fluoride by factor 8.3 ± 6.4 compared with the contralateral side (p < 0.01). Bone density in the cortical area was 75 ± 16 % of the contralateral side (p < 0.03). The patient with the largest defect sustained an implant failure in the distal femur and finally accomplished therapy by segmental transport. He also had the lowest uptake of fluoride of the patient collective (2.2-fold increase).
Conclusion
Stem cell concentrates can be an alternative to segmental bone transport. Further studies are needed to compare this method with autologous bone grafting and segmental transport.
Similar content being viewed by others
References
Jager M, Herten M, Fochtmann U et al (2011) Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 29(2):173–180
Al-Zube L, Breitbart EA, O’Connor JP et al (2009) Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res 27(8):1074–1081
Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2(2–3):81–96
Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2(1):1–13
Ghodadra N, Singh K (2008) Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biogeosciences 2(3):345–354
Giannoudis PV, Tzioupis C (2005) Clinical applications of BMP-7: the UK perspective. Injury 36(Suppl 3):S47–S50
Dimitriou R, Dahabreh Z, Katsoulis E et al (2005) Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36(Suppl 4):S51–S59
Graham S, Leonidou A, Lester M et al (2009) Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs 18(11):1633–1654
Hollinger JO, Hart CE, Hirsch SN et al (2008) Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 90(Suppl 1):48–54
Hollinger JO, Onikepe AO, MacKrell J et al (2008) Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26(1):83–90
Kasten P, Vogel J, Geiger F et al (2008) The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29(29):3983–3992
Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35(9):1271–1280
Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31(6):721–727
Hendrich C, Franz E, Waertel G et al (2009) Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients. Orthop Rev (Pavia) 1(2):e32
Jager M, Jelinek EM, Wess KM et al (2009) Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther 4(1):34–43
Gessmann J, Köller M, Godry H et al (2012) Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia) 4(1):e14
Schliephake H, Berding G, Knapp WH, Sewilam S (1999) Monitoring of graft perfusion and osteoblast activity in revascularised fibula segments using [18F]-positron emission tomography. Int J Oral Maxillofac Surg 28(5):349–355
Guda T, Walker JA, Singleton BM et al (2013) Guided bone regeneration in long-bone defects with a structural hydroxyapatite graft and collagen membrane. Tissue Eng Part A 19(17–18):1879–1888
Reichert JC, Cipitria A, Epari DR et al (2012) A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med 4(141):141ra93
Goshima K, Nakase J, Xu Q et al (2012) Repair of segmental bone defects in rabbit tibia promoted by a complex of beta-tricalcium phosphate and hepatocyte growth factor. J Orthop Sci 17(5):639–648
Sauerbier S, Rickert D, Gutwald R et al (2011) Bone marrow concentrate and bovine bone mineral for sinus floor augmentation: a controlled, randomized, single-blinded clinical and histological trial-per-protocol analysis. Tissue Eng Part A 17(17–18):2187–2197
Rickert D, Sauerbier S, Nagursky H et al (2011) Maxillary sinus floor elevation with bovine bone mineral combined with either autogenous bone or autogenous stem cells: a prospective randomized clinical trial. Clin Oral Implants Res 22(3):251–258
Zhong W, Sumita Y, Ohba S et al (2012) In vivo comparison of the bone regeneration capability of human bone marrow concentrates vs. platelet-rich plasma. PLoS One 7(7):e40833
Cao L, Liu G, Gan Y et al (2012) The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats. Biomaterials 33(20):5076–5084
Buttaro MA, Constantini J, Comba F, Piccaluga F (2012) The use of femoral struts and impacted cancellous bone allograft in patients with severe femoral bone loss who undergo revision total hip replacement: a three- to nine-year follow-up. J Bone Joint Surg Br 94(2):167–172
Acknowledgments
The authors thank Mrs. Luisa Schäck and Prof. Dr. Andrea Hoffmann from the Laboratory for Biology of the Musculoskeletal System, Trauma Department, Hannover Medical School, for their help with FACS analysis.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Petri, M., Namazian, A., Wilke, F. et al. Repair of segmental long-bone defects by stem cell concentrate augmented scaffolds: a clinical and positron emission tomography - computed tomography analysis. International Orthopaedics (SICOT) 37, 2231–2237 (2013). https://doi.org/10.1007/s00264-013-2087-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-013-2087-y